Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.
about
Default mode network differences between rigidity- and tremor-predominant Parkinson's diseaseIs heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study.Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patientsAccuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnosesPattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PETMyocardial (123)I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson's Disease.The search for biomarkers in Parkinson's disease: a critical review.Single photon-emission computed tomography imaging in early Parkinson's disease.Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.Nonmotor features of Parkinson's disease subtypes.Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease.Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease.Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by 123I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy : AssesWhite matter microstructure damage in tremor-dominant Parkinson's disease patients.Differences in odor identification among clinical subtypes of Parkinson's disease.Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy.The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes.
P2860
Q30843485-6FB6F22F-C8AE-4DCC-AAA1-93215EB90526Q33585003-7BECCBA7-4040-4C49-A922-564492F1C325Q33731267-D2256F98-5BFF-4797-BC2D-50197E6E8B5CQ34401518-F28C260B-32D5-4007-ACB8-0685F7D4CFB2Q34629923-C68EB29D-52BB-4C06-97E9-055D710ECAB1Q35195635-CA0B920D-4A8E-48DD-8398-B6128E8BD1C0Q35630950-74CA5B96-A366-404C-AD91-C560B79406E8Q36247833-91CAC556-A013-40FE-82EE-B2DEB1750633Q36327980-9F00A2D7-C499-4AB1-984A-629B0052141FQ37352054-01F2069F-57FF-49E2-9260-559B8B1A6B15Q37352055-C397CF3D-2039-45EC-A6E5-4024912AACEEQ37711062-AA631EE5-8D02-4CFB-9C26-EB9BE9BE96C8Q38003065-53EAB54D-F09B-4178-B2AE-D134D8486D01Q38531996-F783D026-9758-4CCC-B7FF-26DA3726F893Q38727963-4429C548-7AC5-4527-A2D8-EB827778DEF1Q40000180-E6AF6802-538A-43DF-9683-DD6DEBC6988FQ41517891-251DD022-89B5-4973-9EE9-A4F0D67183D6Q42408447-D17A8E16-F47B-4659-B45C-DE1F6F81B648Q43173986-4E36D760-007E-453C-8A2C-3270F9281E8EQ44995377-832A2E1D-6EB8-452B-A276-BF3086B8622DQ46521682-C73B0E5B-0864-45F5-A1CF-A4E6BF056686Q48147522-9DE4CB1E-B0BA-4B7D-A5CA-2DB49C8BC7CDQ48685391-596F1286-614F-4671-98B9-1607D5CC3596Q50055043-C554903A-FFF9-4E26-9DF1-84CB3A1C3049Q50240007-83127751-123B-488D-9E6C-1ADDE9EDB1ADQ50267949-97147BCB-4020-423E-A4C3-7DD1DD977AA0Q51192358-FC1D41A6-50C4-4C68-8B8B-94531E643344Q53452154-3A89D7F4-4F8E-4352-9653-328C29DC81C1Q55344774-E395EA1C-AA1A-44A0-9289-92D822AAC053
P2860
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@en
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@nl
type
label
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@en
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@nl
prefLabel
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@en
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@nl
P2093
P356
P1433
P1476
Myocardial sympathetic degener ...... notype of Parkinson's disease.
@en
P2093
Carl-Martin Kirsch
Georgios Farmakis
Jörg Spiegel
Samuel Samnick
Ulrich Dillmann
Wolfgang H Jost
P304
P356
10.1002/MDS.21499
P407
P577
2007-05-01T00:00:00Z